Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1986-02-04
1988-03-01
Rotman, Alan L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
514255, 514256, 514333, 514342, 544238, 544331, 544405, 546256, 546271, 546277, 546278, A61K 3138, A61K 31425, A61K 3144, A61K 31495
Patent
active
047286482
ABSTRACT:
New 3,4-diamino-1,2,5-thiadiazole oxide derivatives which are histamine H.sub.1 -antagonists. A specific compound of this invention is 3-[3-[N-(4-fluorobenzyl)-N-pyrid-2-yl-amino]propylamino]-4-[pyrimidin-4-yl -methylamino]-1,2,5-thiadiazole-1-oxide.
REFERENCES:
patent: 4374248 (1983-02-01), Crenshaw et al.
patent: 4394508 (1983-07-01), Crenshaw et al.
patent: 4532246 (1985-07-01), Ife
patent: 4532252 (1985-07-01), Sach
Gribble Andrew D.
Ife Robert J.
Hall Linda E.
Lourie Alan D.
Mullins J. G.
Rotman Alan L.
Smith Kline & French Laboratories Limited
LandOfFree
Histamine antagonist triadiazole derivatives, compositions, and does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Histamine antagonist triadiazole derivatives, compositions, and , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Histamine antagonist triadiazole derivatives, compositions, and will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-998050